SYDNEY, OCT 3 - The George Institute for Global Health will receive $902,000 to evaluate the best treatments for aneurysmal subarachnoid haemorrhage, it was announced today.
This condition, which most commonly affects women aged 40 to 60, will lead to the death of one third of all people afflicted. More than half of those who survive will suffer permanent disability. This clinical trial will help doctors better manage patients with this condition.
SYDNEY, SEPT 27 - Salt sold in supermarkets and salt shakers in restaurants should be required to carry a front-of-pack, tobacco-style health warning, according to The World Hypertension League and leading international health organisations.
SYDNEY, SEPT 23 - The George Institute was today announced as one of 13 Australian organisations to receive an Athena SWAN Bronze Institution Award for its work in advancing gender equity and diversity as part of the Science in Australia Gender Equity (SAGE) initiative.
SYDNEY, SEPT 17 - Half of Australians are living with a chronic illness. A new research-based online test can predict your chances of developing some of the biggest killers: heart disease, kidney disease and diabetes – all of which are largely preventable.
SYDNEY, SEPT 11 - The George Institute for Global Health’s Co-Founder and Principal Director Professor Robyn Norton AO has been nominated as one of The Australian Financial Review’s 2019 top 100 Women of Influence, recognising her leadership and trailblazing efforts in global health and gender equity.
SYDNEY, SEPT 6 - A new meta-analysis published in Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
SYDNEY, SEPT 4 - Researchers from The George Institute for Global Health have been awarded almost $6m in Investigator Grants in the latest round of funding from the National Health and Medical Research Council (NHMRC).